Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
Listen to The Bloodline with LLS
To subscribe to The Bloodline with LLS, click here.
Recent Episodes
Complexities of Secondary AML with Dr. Goldberg
Join us as we speak with Dr. Aaron Goldberg from Memorial Sloan Kettering Cancer Center in New York City. Dr. Goldberg discusses how secondary AML differs from AML and how treatment is determined. Secondary AML is a diagnosis of AML that has occurred after previous exposure to radiation or chemotherapy for another cancer or has evolved from a prior diagnosis of MDS, MPN or Aplastic Anemia. In this episode, Dr. Goldberg points out the major difference between secondary AML and de novo AML and new, promising treatments.
Support for this episode provided by Jazz Pharmaceuticals.
I’m a Caregiver & Advocate: Kristin’s Story
Join us as we speak to Kristin Furhrmann-Simmons, a caregiver and an LLS volunteer. Kristin talks to us about caring for her father who is a CLL survivor, and how she decided to join LLS’s advocacy efforts through our Office of Public Policy. For Kristin, it was a great way to connect with people in her community and share her family’s story. And she knew that for her dad, being as sick as he was, it was helpful to have her as his voice to bring forward some of the issues that her family was facing as a result of his treatment. This episode highlights how advocates carry the ability to uphold a voice that may have been silenced by a diagnosis.
Your Questions Answered About Hodgkin Lymphoma
Dr. Hoffman from the Sylvester Comprehensive Cancer Center, University of Miami Health System in Miami, Florida speaks to us about Hodgkin lymphoma and its interesting history. Thankfully, Hodgkin lymphoma is now highly treatable and for the majority of people curable, but not for all. Dr. Hoffman talks to us about what makes Hodgkin lymphoma unique, as well as discusses emerging therapies and long term and late effects for both young adult and older patients diagnosed with Hodgkin lymphoma.
Support for this episode provided by Seattle Genetics.
Listen to The Bloodline with LLS
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.